Sarepta Therapeutics (SRPT) Tax Provisions (2017 - 2026)
Sarepta Therapeutics' quarterly Tax Provisions came in at $12.2 million in Q1 2026, down 80.91% year-on-year from $64.0 million in Q1 2025, and up 148.58% quarter-over-quarter from $4.9 million in Q4 2025.
Sarepta Therapeutics has reported Tax Provisions for 10 years, with the latest figure at $12.2 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 80.91% year-over-year to $12.2 million; the trailing twelve-month figure through Mar 2026 stood at -$40.2 million (down 147.64% YoY), and the FY2025 full-year result was $11.5 million, down 55.21% from the prior year.
- Tax Provisions for Q1 2026 stood at $12.2 million, up from $4.9 million in the prior quarter.
- The five-year high for Tax Provisions was $64.0 million in Q1 2025, with the low at -$43.3 million in Q2 2025.
- Average Tax Provisions over 5 years is $4.0 million, with a median of $4.9 million recorded in 2025.
- Year-over-year, Tax Provisions soared 8528.26% in 2022 and plunged 3625.0% in 2025.
- Tracing SRPT's Tax Provisions over 5 years: stood at $7.9 million in 2022, then slumped by 314.41% to -$17.0 million in 2023, then soared by 176.05% to $12.9 million in 2024, then tumbled by 62.03% to $4.9 million in 2025, then soared by 148.58% to $12.2 million in 2026.
- The last three Tax Provisions figures came in at $12.2 million (Q1 2026), $4.9 million (Q4 2025), and -$14.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 12.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.22 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | -14.10 Mn |
| Jun 30, 2025 | -43.25 Mn |
| Mar 31, 2025 | 63.99 Mn |
| Dec 31, 2024 | 12.94 Mn |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 7.10 Mn |
| Mar 31, 2024 | 5.30 Mn |
| Dec 31, 2023 | -17.02 Mn |
| Sep 30, 2023 | 7.76 Mn |
| Jun 30, 2023 | 9.36 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | 7.94 Mn |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 3.39 Mn |
| Mar 31, 2022 | 879,000.00 |
| Dec 31, 2021 | 92,000.00 |
| Sep 30, 2021 | 237,000.00 |
| Jun 30, 2021 | -354,000.00 |
| Mar 31, 2021 | -143,000.00 |
| Dec 31, 2020 | 832,000.00 |
| Sep 30, 2020 | 96,000.00 |
| Jun 30, 2020 | 20,000.00 |
| Mar 31, 2020 | 115,000.00 |
| Dec 31, 2019 | 711,000.00 |
| Sep 30, 2019 | 226,000.00 |
| Jun 30, 2019 | 174,000.00 |
| Mar 31, 2019 | 84,000.00 |
| Dec 31, 2018 | -779,000.00 |
| Sep 30, 2018 | -674,000.00 |
| Jun 30, 2018 | 622,000.00 |
| Mar 31, 2018 | 139,000.00 |
| Dec 31, 2017 | -1.84 Mn |
| Sep 30, 2017 | 2.01 Mn |
| Jun 30, 2017 | -109,000.00 |
| Mar 31, 2017 | 2.00 Mn |